-
公开(公告)号:EP3784214B1
公开(公告)日:2024-11-13
申请号:EP19793833.5
申请日:2019-04-24
-
-
公开(公告)号:EP4456875A1
公开(公告)日:2024-11-06
申请号:EP22844563.1
申请日:2022-12-30
申请人: a Fine House S.A.
发明人: LIOLIOS, Georgios
IPC分类号: A61K9/08 , A61K31/454 , A61K47/10 , A61K47/26
-
公开(公告)号:EP4406535A3
公开(公告)日:2024-11-06
申请号:EP24168728.4
申请日:2014-10-31
申请人: Allergan, Inc.
IPC分类号: A61K9/16 , A61K47/10 , A61K47/34 , A61K31/5575 , A61P27/02 , A61P27/06 , A61K31/165
摘要: Prostamide-containing intraocular implants that biodegrade in the eye and that are effective for reducing intraocular pressure in an eye for a sustained period. The implants generally contain a prostamide, such as bimatoprost, and at least three distinct biodegradable polymers selected from polylactide and poly(lactide-co-glycolide) polymers and are optimized for placement in and compatibility with the anterior chamber of the eye, particularly the anterior chamber angle. Methods for making and using the implants to reduce ocular hypertension and intraocular pressure in a patient are described.
-
5.
公开(公告)号:EP4452322A2
公开(公告)日:2024-10-30
申请号:EP23753385.6
申请日:2023-02-08
发明人: WEBBER, Matthew , XIANG, Yuanhui , XIAN, Sijie
-
公开(公告)号:EP4452321A1
公开(公告)日:2024-10-30
申请号:EP22854364.1
申请日:2022-12-21
-
公开(公告)号:EP3148589B1
公开(公告)日:2024-10-30
申请号:EP15800669.2
申请日:2015-05-28
-
公开(公告)号:EP4448584A2
公开(公告)日:2024-10-23
申请号:EP22906839.0
申请日:2022-12-17
-
-
公开(公告)号:EP4389147A3
公开(公告)日:2024-10-23
申请号:EP24174213.9
申请日:2018-08-09
发明人: HEPLER, Douglas , DEMPSEY, Gail L. , JOHNSON, Roland , KELLY, Michael , DANIEL, Michael , PAULSEN, Neil, E. , CLAYTON, Bert
IPC分类号: A61K31/4155 , A61K9/08 , A61P29/00 , A61K47/26 , A61K47/22 , A61K31/485 , A61K31/635 , A61K31/353 , A61K9/00 , A61K47/10
摘要: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
-
-
-
-
-
-
-
-
-